Evidence map›Paper›PMID 31276332›Full record

ArticleAnnals of global health2019

Gastrointestinal Parasitic Infections and Immunological Status of HIV/AIDS Coinfected Individuals in Nigeria.

Emmanuel Ochigbo Udeh, R N N Obiezue, F C Okafor, C B Ikele, I C Okoye, Chidiebere A Otuu

Open access · goldAbstract read
In one paragraph

Article in Annals of global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Prevalence, Genetic Diversity, and Risk Factors ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Tropical medicine and infectious disease · 2025
    Review
  10. Article
  11. Article
  12. Global Burden ofViruses · 2022
    Review
  13. Article
  14. First Molecular Characterization ofPathogens (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emmanuel Ochigbo UdehDepartment of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka, NG.
R N N ObiezueDepartment of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka, NG.
F C OkaforDepartment of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka, NG.
C B IkeleDepartment of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka, NG.
I C OkoyeDepartment of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka, NG.
Chidiebere A OtuuDepartment of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka, NG.
University of Nigeria · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParasitic infections of the gastrointestinal tract is one of the highest causes of morbidity and mortality among HIV infected individuals. This is due to the colonization of the intestinal tract by parasites influenced by induced enteropathy caused by HIV infection. CD+4 t-lymphocytes count is a marker of the immune status of HIV infected individuals.

objectiveThis study investigated the prevalence of gastrointestinal parasitic infections among HIV coinfected individuals in relation to their immunological status.

methodsCD+4 t-lymphocytes count was determined using fluorescence-activated cell sorting (FACS) count system. Parasitological examination of faecal samples was conducted using direct wet mount, modified Z-N and Giemsa stain techniques. All prepared slides were examined under x10 and x40 objectives.

findingsOut of the 891 HIV seropositive participants on antiretroviral therapy that were studied, 641 (71.9%) had CD+4 counts equals to or greater than 500 cells/mm3. All other seropositive participants had CD+4 counts below 500 cells/mm3. Gastrointestinal parasitic infections were recorded in 187 (20.9%) seropositive participants, with females (n = 108, 12.1%) having more infections than males. Multiple gastrointestinal parasitic infections were recorded in 28 (3.1%) seropositive participants. Out of the 150 seronegative participants, 79 (52.7%) of them had at least one gastrointestinal parasitic infection. Female seronegative participants also accounted for higher infection rate (n = 42, 28.0%) than males (n = 37, 24.7%). Multiple infections were also recorded in 18 (12.0%) seronegative individuals. The overall prevalence rate of infection between both positive and negative individuals was 25.5%. There was statistical significant difference in the infections of Cryptosporidium parvum (p < 0.003), Cyclospora cayetanensis (p < 0.011) and Cystoisospora belli (p < 0.011) between HIV seropositive and HIV seronegative individuals. Also, there was statistical significant difference in the infections of hook worm (p < 0.002) and Trichuris trichiura (p < 0.020) between seronegative and seropositive individuals. Gastrointestinal parasitic infection rate was significantly higher among seropositive participants with CD+4 counts between 200 and 350 cells/mm3 (n = 109, 58.3%).

conclusionThe study shows that HIV infected individuals continue to experience gastrointestinal infections even with antiretroviral treatment, especially those with CD+4 counts below 350 cells/mm3. Health care providers should prioritise routine screening of HIV patients for gastrointestinal parasites and provide prompt treatment. Antiparasitic drugs should also be provided as prophylaxis.

Indexed as

Cryptosporidium parvumAdolescentAdultCD4 Lymphocyte CountCoinfectionCryptosporidiosisCyclosporiasisFecesFemaleGastrointestinal DiseasesHIV SeronegativityHIV SeropositivityHumansMaleMiddle AgedNigeria

Identifiers

PMID31276332
PMCPMC6634336
OpenAlexW2953952133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.